Delivery Order SPE2DB22D1052-SPE2DB25FU9LC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,219.00 by the Defense Logistics Agency for 30-count tablets of Arimidex 1 mg. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, was made under firm fixed-price terms with no set-aside designation, indicating the contract was competitively awarded. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.92 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on September 22, 2025, carries a ceiling value of $17,478.93 and has an ultimate completion date of September 23, 2025. This is a non-set-aside competitive award, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.66 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging). The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is issued as a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Arimidex 1 mg tablets (30-count units) valued at $3,417.58. This firm fixed price delivery order is scheduled for completion by August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.82 fixed-price contract is for the delivery of 90-count bottles of the generic drug Anastrozole 1 mg Tablets. The contract has a period of performance through March 28, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Anastrozole 1 mg tablets. The $4,266.59 firm fixed-price contract has a performance period ending on September 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products...
- This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA). The $2,377.16 delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $65,310 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561327557 anastrozole 1 mg tablets (30 count). The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 26, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this contract utilizing its own resources, with no mention of major subcontractors. The award draws upon...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9LCDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,330.95 by the Defense Logistics Agency to supply 30-tablet containers of Arimidex 1 mg tablets. The order was competitively awarded without set-aside designation under a firm fixed-price contract structure, with an ultimate completion date of June 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, the company maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle under which this award falls represents a strategic relationship enabling the company to supply a broad range of pharmaceutical products globally to support federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 6/21/25 |